Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016 (2016), Article ID 9508541, 18 pages
http://dx.doi.org/10.1155/2016/9508541
Review Article

Neuroprotection as a Therapeutic Target for Diabetic Retinopathy

1CIBERDEM (CIBER de Diabetes y Enfermedades Metabolicas Asociadas) and Diabetes and Metabolism Research Unit, Vall d’Hebron Institut de Recerca (VHIR), Universitat Autonoma de Barcelona, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain
2Department of Biology, University of Pisa, Via San Zeno 31, 56127 Pisa, Italy
3Interdepartmental Research Center Nutrafood “Nutraceuticals and Food for Health”, University of Pisa, Via del Borghetto 80, 56124 Pisa, Italy

Received 22 December 2015; Revised 29 February 2016; Accepted 16 March 2016

Academic Editor: Ronald G. Tilton

Copyright © 2016 Cristina Hernández et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. F. Abcouwer and T. W. Gardner, “Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment,” Annals of the New York Academy of Sciences, vol. 1311, pp. 174–190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Ola, M. I. Nawaz, M. M. Siddiquei, S. Al-Amro, and A. M. Abu El-Asrar, “Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy,” Journal of Diabetes and Its Complications, vol. 26, no. 1, pp. 56–64, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Qian and H. Ripps, “Neurovascular interaction and the pathophysiology of diabetic retinopathy,” Experimental Diabetes Research, vol. 2011, Article ID 693426, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Tarr, K. Kaul, M. Chopra, E. M. Kohner, and R. Chibber, “Pathophysiology of diabetic retinopathy,” ISRN Ophthalmology, vol. 2013, Article ID 343560, 13 pages, 2013. View at Publisher · View at Google Scholar
  5. D. A. Antonetti, A. J. Barber, S. K. Bronson et al., “Diabetic retinopathy: seeing beyond glucose-induced microvascular disease,” Diabetes, vol. 55, no. 9, pp. 2401–2411, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Hernández and R. Simó, “Neuroprotection in diabetic retinopathy,” Current Diabetes Reports, vol. 12, no. 4, pp. 329–337, 2012. View at Publisher · View at Google Scholar
  7. V. Jindal, “Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy,” Molecular Neurobiology, vol. 51, no. 3, pp. 878–884, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Zhang, N. Wang, G. R. Barile, S. Bao, and M. Gillies, “Diabetic retinopathy: neuron protection as a therapeutic target,” International Journal of Biochemistry and Cell Biology, vol. 45, no. 7, pp. 1525–1529, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Simó and C. Hernández, “Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence,” Progress in Retinal and Eye Research, vol. 48, pp. 160–180, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. Barber, E. Lieth, S. A. Khin, D. A. Antonetti, A. G. Buchanan, and T. W. Gardner, “Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin,” The Journal of Clinical Investigation, vol. 102, no. 4, pp. 783–791, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Yang, Y. Xu, P. Xie et al., “Retinal neurodegeneration in db/db mice at the early period of diabetes,” Journal of Ophthalmology, vol. 2015, Article ID 757412, 9 pages, 2015. View at Publisher · View at Google Scholar
  12. M. Villarroel, A. Ciudin, C. Hernandez, and R. Simo, “Neurodegeneration: an early event of diabetic retinopathy,” World Journal of Diabetes, vol. 1, no. 2, pp. 57–64, 2010. View at Publisher · View at Google Scholar
  13. A. J. Adams and M. A. Bearse Jr., “Retinal neuropathy precedes vasculopathy in diabetes: a function-based opportunity for early treatment intervention?” Clinical and Experimental Optometry, vol. 95, no. 3, pp. 256–265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. Barber, “A new view of diabetic retinopathy: a neurodegenerative disease of the eye,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 27, no. 2, pp. 283–290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. A. Feit-Leichman, R. Kinouchi, M. Takeda et al., “Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes,” Investigative Ophthalmology and Visual Science, vol. 46, no. 11, pp. 4281–4287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Yu, L. Wang, S.-J. Weng, X.-L. Yang, D.-Q. Zhang, and Y.-M. Zhong, “Hyperactivity of ON-type retinal ganglion cells in streptozotocin-induced diabetic mice,” PLoS ONE, vol. 8, no. 9, Article ID e76049, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Gubitosi-Klug, R. Talahalli, Y. Du, J. L. Nadler, and T. S. Kern, “5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy,” Diabetes, vol. 57, no. 5, pp. 1387–1393, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. M. Abu-El-Asrar, L. Dralands, L. Missotten, I. A. Al-Jadaan, and K. Geboes, “Expression of apoptosis markers in the retinas of human subjects with diabetes,” Investigative Ophthalmology and Visual Science, vol. 45, no. 8, pp. 2760–2766, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Oshitari, S. Yamamoto, N. Hata, and S. Roy, “Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy,” British Journal of Ophthalmology, vol. 92, no. 4, pp. 552–556, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Abu El-Asrar, L. Dralands, L. Missotten, and K. Geboes, “Expression of antiapoptotic and proapoptotic molecules in diabetic retinas,” Eye, vol. 21, no. 2, pp. 238–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H. W. van Dijk, P. H. B. Kok, M. Garvin et al., “Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 50, no. 7, pp. 3404–3409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. W. van Dijk, F. D. Verbraak, P. H. B. Kok et al., “Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes,” Investigative Ophthalmology and Visual Science, vol. 51, no. 7, pp. 3660–3665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H. W. van Dijk, F. D. Verbraak, P. H. Kok et al., “Early neurodegeneration in the retina of type 2 diabetic patients,” Investigative Opthalmology & Visual Science, vol. 53, no. 6, pp. 2715–2719, 2012. View at Publisher · View at Google Scholar
  24. J. Chhablani, A. Sharma, A. Goud et al., “Neurodegeneration in type 2 diabetes: evidence from spectral-domain optical coherence tomography,” Investigative Ophthalmology and Visual Science, vol. 56, no. 11, pp. 6333–6338, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. A. J. Barber, D. A. Antonetti, T. S. Kern et al., “The Ins2Akita mouse as a model of early retinal complications in diabetes,” Investigative Ophthalmology and Visual Science, vol. 46, no. 6, pp. 2210–2218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. P. M. Martin, P. Roon, T. K. Van Ells, V. Ganapathy, and S. B. Smith, “Death of retinal neurons in streptozotocin-induced diabetic mice,” Investigative Ophthalmology and Visual Science, vol. 45, no. 9, pp. 3330–3336, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Y.-H. Li, Y.-H. Zhuo, L. Lü et al., “Caspase-dependent retinal ganglion cell apoptosis in the rat model of acute diabetes,” Chinese Medical Journal, vol. 121, no. 24, pp. 2566–2571, 2008. View at Google Scholar · View at Scopus
  28. R. A. Kowluru and S. N. Abbas, “Diabetes-induced mitochondrial dysfunction in the retina,” Investigative Ophthalmology and Visual Science, vol. 44, no. 12, pp. 5327–5334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Bogdanov, L. Corraliza, J. A. Villena et al., “The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration,” PLoS ONE, vol. 9, no. 5, Article ID e97302, 2014. View at Publisher · View at Google Scholar
  30. J. H. Yang, H. W. Kwak, T. G. Kim, J. Han, S. W. Moon, and S. Y. Yu, “Retinal neurodegeneration in type II diabetic Otsuka long-evans Tokushima fatty rats,” Investigative Ophthalmology and Visual Science, vol. 54, no. 6, pp. 3844–3851, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. F. I. Baptista, M. J. Pinto, F. Elvas, T. Martins, R. D. Almeida, and A. F. Ambrósio, “Diabetes induces changes in KIF1A, KIF5B and dynein distribution in the rat retina: implications for axonal transport,” Experimental Eye Research, vol. 127, pp. 91–103, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. T. S. D'Cruz, B. N. Weibley, S. R. Kimball, and A. J. Barber, “Post-translational processing of synaptophysin in the rat retina is disrupted by diabetes,” PLoS ONE, vol. 7, no. 9, Article ID e44711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Gaspar, F. I. Baptista, J. Galvão, Á. F. Castilho, R. A. Cunha, and A. F. Ambrósio, “Diabetes differentially affects the content of exocytotic proteins in hippocampal and retinal nerve terminals,” Neuroscience, vol. 169, no. 4, pp. 1589–1600, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. H. D. VanGuilder, R. M. Brucklacher, K. Patel, R. W. Ellis, W. M. Freeman, and A. J. Barber, “Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina,” European Journal of Neuroscience, vol. 28, no. 1, pp. 1–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. T. S. Kern and A. J. Barber, “Retinal ganglion cells in diabetes,” Journal of Physiology, vol. 586, no. 18, pp. 4401–4408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Liu, Z. Zuo, W. Liu et al., “Upregulation of Nogo receptor expression induces apoptosis of retinal ganglion cells in diabetic rats,” Neural Regeneration Research, vol. 9, no. 8, pp. 815–820, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Szabadfi, T. Atlasz, P. Kiss et al., “Protective effects of the neuropeptide PACAP in diabetic retinopathy,” Cell and Tissue Research, vol. 348, no. 1, pp. 37–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. T. K. Ali, S. Matragoon, B. A. Pillai, G. I. Liou, and A. B. El-Remessy, “Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes,” Diabetes, vol. 57, no. 4, pp. 889–898, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. Gastinger, R. S. J. Singh, and A. J. Barber, “Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas,” Investigative Ophthalmology & Visual Science, vol. 47, no. 7, pp. 3143–3150, 2006. View at Publisher · View at Google Scholar
  40. M. Seki, T. Tanaka, H. Nawa et al., “Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells,” Diabetes, vol. 53, no. 9, pp. 2412–2419, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Roufail, T. Soulis, E. Boel, M. E. Cooper, and S. Rees, “Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine,” Diabetologia, vol. 41, no. 12, pp. 1419–1425, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. M. H. Aung, H. N. Park, M. K. Han et al., “Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes,” The Journal of Neuroscience, vol. 34, no. 3, pp. 726–736, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. F. I. Baptista, J. M. Gaspar, A. Cristóvão, P. F. Santos, A. Köfalvi, and A. F. Ambrósio, “Diabetes induces early transient changes in the content of vesicular transporters and no major effects in neurotransmitter release in hippocampus and retina,” Brain Research, vol. 1383, pp. 257–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. S.-H. Park, J.-W. Park, S.-J. Park et al., “Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina,” Diabetologia, vol. 46, no. 9, pp. 1260–1268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Aizu, K. Oyanagi, J. Hu, and H. Nakagawa, “Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats,” Neuropathology, vol. 22, no. 3, pp. 161–170, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. S. V. Logvinov, M. B. Plotnikov, A. A. Zhdankina et al., “Morphological changes in retinal neurons in streptozotocin-induced diabetes mellitus and their correction with an isobornylphenol derivative,” Neuroscience and Behavioral Physiology, vol. 40, no. 7, pp. 779–782, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Lombardo, M. Parravano, G. Lombardo et al., “Adaptive optics imaging of parafoveal cones in type 1 diabetes,” Retina, vol. 34, no. 3, pp. 546–557, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. T. S. Kern and B. A. Berkowitz, “Photoreceptors in diabetic retinopathy,” Journal of Diabetes Investigation, vol. 6, no. 4, pp. 371–380, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. M. J. Gastinger, A. J. Barber, S. A. Khin, C. S. McRill, T. W. Gardner, and D. W. Marshak, “Abnormal centrifugal axons in streptozotocin-diabetic rat retinas,” Investigative Ophthalmology and Visual Science, vol. 42, no. 11, pp. 2679–2685, 2001. View at Google Scholar · View at Scopus
  50. M. J. Gastinger, A. R. Kunselman, E. E. Conboy, S. K. Bronson, and A. J. Barber, “Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2Akita diabetic mice,” Investigative Ophthalmology and Visual Science, vol. 49, no. 6, pp. 2635–2642, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. J. R. Wolter, “Diabetic retinopathy,” American Journal of Ophthalmology, vol. 51, no. 5, pp. 1123–1141, 1961. View at Google Scholar · View at Scopus
  52. D. C. Fernandez, L. A. Pasquini, D. Dorfman, H. J. Aldana Marcos, and R. E. Rosenstein, “Early distal axonopathy of the visual pathway in experimental diabetes,” The American Journal of Pathology, vol. 180, no. 1, pp. 303–313, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Zhang, M. Inoue, K. Dong, and M. Yamamoto, “Alterations in retrograde axonal transport in optic nerve of type I and type II diabetic rats,” Kobe Journal of Medical Sciences, vol. 44, no. 5-6, pp. 205–215, 1998. View at Google Scholar · View at Scopus
  54. S. Bonnin, R. Tadayoni, A. Erginay, P. Massin, and B. Dupas, “Correlation between ganglion cell layer thinning and poor visual function after resolution of diabetic macular edema,” Investigative Ophthalmology and Visual Science, vol. 56, no. 2, pp. 978–982, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. B. V. Bui, M. Loeliger, M. Thomas et al., “Investigating structural and biochemical correlates of ganglion cell dysfunction in streptozotocin-induced diabetic rats,” Experimental Eye Research, vol. 88, no. 6, pp. 1076–1083, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. J. A. Phipps, E. L. Fletcher, and A. J. Vingrys, “Paired-flash identification of rod and cone dysfunction in the diabetic rat,” Investigative Ophthalmology and Visual Science, vol. 45, no. 12, pp. 4592–4600, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. Q. Li, E. Zemel, B. Miller, and I. Perlman, “Early retinal damage in experimental diabetes: electroretinographical and morphological observations,” Experimental Eye Research, vol. 74, no. 5, pp. 615–625, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. D. Yonemura, T. Aoki, and K. Tsuzuki, “Electroretinogram in diabetic retinopathy,” Archives of Ophthalmology, vol. 68, pp. 19–24, 1962. View at Publisher · View at Google Scholar · View at Scopus
  59. M. A. Bearse Jr., A. J. Adams, Y. Han et al., “A multifocal electroretinogram model predicting the development of diabetic retinopathy,” Progress in Retinal and Eye Research, vol. 25, no. 5, pp. 425–448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. G. H. Bresnick and M. Palta, “Oscillatory potential amplitudes. Relation to severity of diabetic retinopathy,” Archives of Ophthalmology, vol. 105, no. 7, pp. 929–933, 1987. View at Publisher · View at Google Scholar · View at Scopus
  61. E. Lakhani, T. Wright, M. Abdolell, and C. Westall, “Multifocal ERG defects associated with insufficient long-term glycemic control in adolescents with type 1 diabetes,” Investigative Ophthalmology and Visual Science, vol. 51, no. 10, pp. 5297–5303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. M. McFarlane, T. Wright, D. Stephens, J. Nilsson, and C. A. Westall, “Blue flash ERG PhNR changes associated with poor long-term glycemic control in adolescents with type 1 diabetes,” Investigative Ophthalmology and Visual Science, vol. 53, no. 2, pp. 741–748, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Holopigian, W. Seiple, M. Lorenzo, and R. Carr, “A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 33, no. 10, pp. 2773–2780, 1992. View at Google Scholar · View at Scopus
  64. B. E. Wolff, M. A. Bearse, M. E. Schneck et al., “Color vision and neuroretinal function in diabetes,” Documenta Ophthalmologica, vol. 130, no. 2, pp. 131–139, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. L. C. O. Andrade, G. S. Souza, E. M. C. B. Lacerda et al., “Influence of retinopathy on the achromatic and chromatic vision of patients with type 2 diabetes,” BMC Ophthalmology, vol. 14, article 104, pp. 1471–2415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Simó and C. Hernández, “Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications,” British Journal of Ophthalmology, vol. 96, no. 10, pp. 1285–1290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Reis, C. Mateus, P. Melo, J. Figueira, J. Cunha-Vaz, and M. Castelo-Branco, “Neuroretinal dysfunction with intact blood-retinal barrier and absent vasculopathy in type 1 diabetes,” Diabetes, vol. 63, no. 11, pp. 3926–3937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. W. Tan, T. Wright, A. Dupuis, E. Lakhani, and C. Westall, “Localizing functional damage in the neural retina of adolescents and young adults with type 1 diabetes,” Investigative Ophthalmology and Visual Science, vol. 55, no. 4, pp. 2432–2441, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Chen, T. M. Curtis, and A. W. Stitt, “Advanced glycation end products and diabetic retinopathy,” Current Medicinal Chemistry, vol. 20, no. 26, pp. 3234–3240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Zong, M. Ward, and A. W. Stitt, “AGEs, RAGE, and diabetic retinopathy,” Current Diabetes Reports, vol. 11, no. 4, pp. 244–252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. B.-H. Chen, D.-Y. Jiang, and L.-S. Tang, “Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes,” Life Sciences, vol. 79, no. 11, pp. 1040–1048, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. B. Liu, M. Bhat, A. K. Padival, D. G. Smith, and R. H. Nagaraj, “Effect of dicarbonyl modification of fibronectin on retinal capillary pericytes,” Investigative Ophthalmology and Visual Science, vol. 45, no. 6, pp. 1983–1995, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. R. Chibber, P. A. Molinatti, N. Rosatto, B. Lambourne, and E. M. Kohner, “Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy,” Diabetologia, vol. 40, no. 2, pp. 156–164, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. A. W. Stitt, C. McGoldrick, A. Rice-McCaldin et al., “Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3,” Diabetes, vol. 54, no. 3, pp. 785–794, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Nitti, A. L. Furfaro, N. Traverso et al., “PKC delta and NADPH oxidase in AGE-induced neuronal death,” Neuroscience Letters, vol. 416, no. 3, pp. 261–265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Zong, M. Ward, A. Madden et al., “Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE),” Diabetologia, vol. 53, no. 12, pp. 2656–2666, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Kim, C.-S. Kim, Y. M. Lee, E. Sohn, K. Jo, and J. S. Kim, “Litsea japonica extract inhibits neuronal apoptosis and the accumulation of advanced glycation end products in the diabetic mouse retina,” Molecular Medicine Reports, vol. 12, no. 1, pp. 1075–1081, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Kim, C.-S. Kim, E. Sohn et al., “Aminoguanidine protects against apoptosis of retinal ganglion cells in Zucker diabetic fatty rats,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 11, pp. 1573–1578, 2014. View at Google Scholar · View at Scopus
  79. A. Lecleire-Collet, L. H. Tessier, P. Massin et al., “Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants,” British Journal of Ophthalmology, vol. 89, no. 12, pp. 1631–1633, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Reber, R. Geffarth, M. Kasper et al., “Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 241, no. 3, pp. 213–225, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Dal Monte, R. Amato, M. Biagioni, M. Cammalleri, and G. Casini, “Neuroprotection as a therapeutic target in diabetic retinopathy: a basic approach,” Acta Ophthalmologica, vol. 93, supplement S255, 2015. View at Publisher · View at Google Scholar
  82. E. Lieth, A. J. Barber, B. Xu et al., “Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group,” Diabetes, vol. 47, no. 5, pp. 815–820, 1998. View at Publisher · View at Google Scholar · View at Scopus
  83. E. Lieth, K. F. LaNoue, D. A. Antonetti, M. Ratz, and The Penn State Retina Research Group, “Diabetes reduces glutamate oxidation and glutamine synthesis in the retina,” Experimental Eye Research, vol. 70, no. 6, pp. 723–730, 2000. View at Publisher · View at Google Scholar · View at Scopus
  84. R. A. Kowluru, R. L. Engerman, G. L. Case, and T. S. Kern, “Retinal glutamate in diabetes and effect of antioxidants,” Neurochemistry International, vol. 38, no. 5, pp. 385–390, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. Y.-K. Ng, X.-X. Zeng, and E.-A. Ling, “Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats,” Brain Research, vol. 1018, no. 1, pp. 66–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. A. F. Castilho, J. T. Liberal, F. I. Baptista, J. M. Gaspar, A. L. Carvalho, and A. F. Ambrósio, “Elevated glucose concentration changes the content and cellular localization of AMPA receptors in the retina but not in the hippocampus,” Neuroscience, vol. 219, pp. 23–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. A. R. Santiago, S. C. Rosa, P. F. Santos, A. J. Cristóvão, A. J. Barber, and A. F. Ambrósio, “Elevated glucose changes the expression of ionotropic glutamate receptor subunits and impairs calcium homeostasis in retinal neural cells,” Investigative Ophthalmology and Visual Science, vol. 47, no. 9, pp. 4130–4137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. A. R. Santiago, J. M. Gaspar, F. I. Baptista et al., “Diabetes changes the levels of ionotropic glutamate receptors in the rat retina,” Molecular Vision, vol. 15, pp. 1620–1630, 2009. View at Google Scholar · View at Scopus
  89. J. Ambati, K. V. Chalam, D. K. Chawala et al., “Elevated γ-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy,” Archives of Ophthalmology, vol. 115, no. 9, pp. 1161–1166, 1997. View at Publisher · View at Google Scholar · View at Scopus
  90. M.-J. Lu, J. S. Pulido, C. A. McCannel et al., “Detection of elevated signaling amino acids in human diabetic vitreous by rapid capillary electrophoresis,” Experimental Diabesity Research, vol. 2007, Article ID 39765, 6 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. A. R. Santiago, J. M. Hughes, W. Kamphuis, R. O. Schlingemann, and A. F. Ambrósio, “Diabetes changes ionotropic glutamate receptor subunit expression level in the human retina,” Brain Research, vol. 1198, pp. 153–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. Q. Li and D. G. Puro, “Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells,” Investigative Ophthalmology and Visual Science, vol. 43, no. 9, pp. 3109–3116, 2002. View at Google Scholar · View at Scopus
  93. K. H. Gabbay, “The sorbitol pathway and the complications of diabetes,” The New England Journal of Medicine, vol. 288, no. 16, pp. 831–836, 1973. View at Publisher · View at Google Scholar · View at Scopus
  94. I. G. Obrosova and P. F. Kador, “Aldose reductase/polyol inhibitors for diabetic retinopathy,” Current Pharmaceutical Biotechnology, vol. 12, no. 3, pp. 373–385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. Z. Dagher, Y. S. Park, V. Asnaghi, T. Hoehn, C. Gerhardinger, and M. Lorenzi, “Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy,” Diabetes, vol. 53, no. 9, pp. 2404–2411, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. C. A. Lee, G. Li, M. D. Patel et al., “Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, RAGE, leukocytes, and aldose reductase,” Investigative Ophthalmology and Visual Science, vol. 55, no. 5, pp. 2904–2910, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Lorenzi, “The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient,” Experimental Diabetes Research, vol. 2007, Article ID 61038, 10 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. V. R. Drel, W. Xu, J. Zhang et al., “Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats,” Investigative Ophthalmology and Visual Science, vol. 50, no. 4, pp. 1778–1790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. L. Zheng, C. Szabó, and T. S. Kern, “Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-κB,” Diabetes, vol. 53, no. 11, pp. 2960–2967, 2004. View at Publisher · View at Google Scholar · View at Scopus
  100. I. G. Obrosova and U. A. Julius, “Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy,” Current Vascular Pharmacology, vol. 3, no. 3, pp. 267–283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  101. G. Mohammad, M. M. Siddiquei, and A. M. Abu El-Asrar, “Poly (ADP-Ribose) polymerase mediates diabetes-induced retinal neuropathy,” Mediators of Inflammation, vol. 2013, Article ID 510451, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Z. Safi, R. Qvist, S. Kumar, K. Batumalaie, and I. S. B. Ismail, “Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets,” BioMed Research International, vol. 2014, Article ID 801269, 18 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Nakamura, A. J. Barber, D. A. Antonetti et al., “Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons,” The Journal of Biological Chemistry, vol. 276, no. 47, pp. 43748–43755, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. T. E. Fox, M. M. Young, M. M. Pedersen, S. Giambuzzi-Tussey, M. Kester, and T. W. Gardner, “Insulin signaling in retinal neurons is regulated within cholesterol-enriched membrane microdomains,” American Journal of Physiology—Endocrinology and Metabolism, vol. 300, no. 3, pp. E600–E609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. T. Behl, I. Kaur, and A. Kotwani, “Implication of oxidative stress in progression of diabetic retinopathy,” Survey of Ophthalmology, vol. 61, no. 2, pp. 187–196, 2016. View at Publisher · View at Google Scholar
  106. D. M. van Reyk, M. C. Gillies, and M. J. Davies, “The retina: oxidative stress and diabetes,” Redox Report, vol. 8, no. 4, pp. 187–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Sasaki, Y. Ozawa, T. Kurihara et al., “Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes,” Diabetologia, vol. 53, no. 5, pp. 971–979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. L. Zheng and T. S. Kern, “Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy,” Frontiers in Bioscience, vol. 14, no. 10, pp. 3974–3987, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. R. A. Kowluru, “Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated,” Acta Diabetologica, vol. 38, no. 4, pp. 179–185, 2001. View at Publisher · View at Google Scholar · View at Scopus
  110. M. Coucha, S. L. Elshaer, W. S. Eldahshan, B. A. Mysona, and A. B. El-Remessy, “Molecular mechanisms of diabetic retinopathy: potential therapeutic targets,” Middle East African Journal of Ophthalmology, vol. 22, no. 2, pp. 135–144, 2015. View at Publisher · View at Google Scholar · View at Scopus
  111. C. Piperi, A. Goumenos, C. Adamopoulos, and A. G. Papavassiliou, “AGE/RAGE signalling regulation by miRNAs: associations with diabetic complications and therapeutic potential,” International Journal of Biochemistry and Cell Biology, vol. 60, pp. 197–201, 2015. View at Publisher · View at Google Scholar · View at Scopus
  112. M. J. Giese and R. C. Speth, “The ocular renin-angiotensin system: a therapeutic target for the treatment of ocular disease,” Pharmacology and Therapeutics, vol. 142, no. 1, pp. 11–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  113. J. L. Wilkinson-Berka, “Angiotensin and diabetic retinopathy,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 5-6, pp. 752–765, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. J. L. Wilkinson-Berka, A. Agrotis, and D. Deliyanti, “The retinal renin-angiotensin system: roles of angiotensin II and aldosterone,” Peptides, vol. 36, no. 1, pp. 142–150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. B. V. Bui, J. A. Armitage, M. Tolcos, M. E. Cooper, and A. J. Vingrys, “ACE inhibition salvages the visual loss caused by diabetes,” Diabetologia, vol. 46, no. 3, pp. 401–408, 2003. View at Google Scholar · View at Scopus
  116. T. Kurihara, Y. Ozawa, N. Nagai et al., “Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina,” Diabetes, vol. 57, no. 8, pp. 2191–2198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. T. Sugiyama, T. Okuno, M. Fukuhara et al., “Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes,” Experimental Eye Research, vol. 85, no. 3, pp. 406–412, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. K. C. Silva, M. A. B. Rosales, S. K. Biswas, J. B. L. De Faria, and J. M. L. De Faria, “Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes,” Diabetes, vol. 58, no. 6, pp. 1382–1390, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. A. M. Joussen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” The FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. Y. Yu, H. Chen, and S. B. Su, “Neuroinflammatory responses in diabetic retinopathy,” Journal of Neuroinflammation, vol. 12, article 141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  121. S. B. Beynon and F. R. Walker, “Microglial activation in the injured and healthy brain: what are we really talking about? Practical and theoretical issues associated with the measurement of changes in microglial morphology,” Neuroscience, vol. 225, pp. 162–171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. E. Polazzi and B. Monti, “Microglia and neuroprotection: from in vitro studies to therapeutic applications,” Progress in Neurobiology, vol. 92, no. 3, pp. 293–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. M. Mizutani, C. Gerhardinger, and M. Lorenzi, “Muller cell changes in human diabetic retinopathy,” Diabetes, vol. 47, no. 3, pp. 445–449, 1998. View at Publisher · View at Google Scholar · View at Scopus
  124. X. Liu, F. Ye, H. Xiong et al., “IL-1β Induces IL-6 production in retinal Müller cells predominantly through the activation of P38 MAPK/NF-κB signaling pathway,” Experimental Cell Research, vol. 331, no. 1, pp. 223–231, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. C. Gerhardinger, M. B. Costa, M. C. Coulombe, I. Toth, T. Hoehn, and P. Grosu, “Expression of acute-phase response proteins in retinal Muller cells in diabetes,” Investigative Ophthalmology and Visual Science, vol. 46, no. 1, pp. 349–357, 2005. View at Publisher · View at Google Scholar · View at Scopus
  126. T. C. Frank-Cannon, L. T. Alto, F. E. McAlpine, and M. G. Tansey, “Does neuroinflammation fan the flame in neurodegenerative diseases?” Molecular Neurodegeneration, vol. 4, article 47, pp. 1750–1326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  127. M. E. Lull and M. L. Block, “Microglial activation and chronic neurodegeneration,” Neurotherapeutics, vol. 7, no. 4, pp. 354–365, 2010. View at Publisher · View at Google Scholar · View at Scopus
  128. S. X. Zhang, E. Sanders, S. J. Fliesler, and J. J. Wang, “Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration,” Experimental Eye Research, vol. 125, pp. 30–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  129. M. Shimazawa, A. Miwa, Y. Ito, K. Tsuruma, M. Aihara, and H. Hara, “Involvement of endoplasmic reticulum stress in optic nerve degeneration following N-methyl-D-aspartate-induced retinal damage in mice,” Journal of Neuroscience Research, vol. 90, no. 10, pp. 1960–1969, 2012. View at Publisher · View at Google Scholar · View at Scopus
  130. L. P. Yang, L. M. Wu, D. M. Wang et al., “Role of endoplasmic reticulum stress in the loss of retinal ganglion cells in diabetic retinopathy,” Neural Regeneration Research, vol. 8, no. 33, pp. 3148–3158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  131. C. E. N. Reiter, L. Sandirasegarane, E. B. Wolpert et al., “Characterization of insulin signaling in rat retina in vivo and ex vivo,” American Journal of Physiology—Endocrinology and Metabolism, vol. 285, no. 4, pp. E763–E774, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. X. Wu, C. E. N. Reiter, D. A. Antonetti, S. R. Kimball, L. S. Jefferson, and T. W. Gardner, “Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner,” Journal of Biological Chemistry, vol. 279, no. 10, pp. 9167–9175, 2004. View at Publisher · View at Google Scholar · View at Scopus
  133. A. J. Barber, M. Nakamura, E. B. Wolpert et al., “Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3,” Journal of Biological Chemistry, vol. 276, no. 35, pp. 32814–32821, 2001. View at Publisher · View at Google Scholar · View at Scopus
  134. C. E. N. Reiter, X. Wu, L. Sandirasegarane et al., “Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin,” Diabetes, vol. 55, no. 4, pp. 1148–1156, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. C. Gerhardinger, K. D. McClure, G. Romeo, F. Podestà, and M. Lorenzi, “IGF-I mRNA and signaling in the diabetic retina,” Diabetes, vol. 50, no. 1, pp. 175–183, 2001. View at Publisher · View at Google Scholar · View at Scopus
  136. A. Kummer, B. E. Pulford, D. N. Ishii, and G. M. Seigel, “Des(1–3)IGF-1 treatment normalizes type 1 IGF receptor and phospho-Akt (Thr 308) immunoreactivity in predegenerative retina of diabetic rats,” Experimental Diabesity Research, vol. 4, no. 1, pp. 45–57, 2003. View at Publisher · View at Google Scholar · View at Scopus
  137. C. J. Barnstable and J. Tombran-Tink, “Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential,” Progress in Retinal and Eye Research, vol. 23, no. 5, pp. 561–577, 2004. View at Publisher · View at Google Scholar · View at Scopus
  138. B. Zheng, T. Li, H. Chen, X. Xu, and Z. Zheng, “Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 152, no. 6, pp. 1039–1043, 2011. View at Publisher · View at Google Scholar · View at Scopus
  139. X. Shen, Y. Zhong, B. Xie, Y. Cheng, and Q. Jiao, “Pigment epithelium derived factor as an anti-inflammatory factor against decrease of glutamine synthetase expression in retinal Müller cells under high glucose conditions,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 8, pp. 1127–1136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  140. B. Xie, Q. Jiao, Y. Cheng, Y. Zhong, and X. Shen, “Effect of pigment epithelium-derived factor on glutamate uptake in retinal Müller cells under high-glucose conditions,” Investigative Ophthalmology and Visual Science, vol. 53, no. 2, pp. 1023–1032, 2012. View at Publisher · View at Google Scholar · View at Scopus
  141. A. M. Abu El-Asrar, G. Mohammad, G. De Hertogh et al., “Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy,” PLoS ONE, vol. 8, no. 6, Article ID e65472, 2013. View at Publisher · View at Google Scholar · View at Scopus
  142. M. M. H. Al-Gayyar, S. Matragoon, B. A. Pillai, T. K. Ali, M. A. Abdelsaid, and A. B. El-Remessy, “Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor proNGF expression in a rat model of diabetes,” Diabetologia, vol. 54, no. 3, pp. 669–680, 2011. View at Publisher · View at Google Scholar · View at Scopus
  143. B. A. Mysona, M. M. H. Al-Gayyar, S. Matragoon et al., “Modulation of p75NTR prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats,” Diabetologia, vol. 56, no. 10, pp. 2329–2339, 2013. View at Publisher · View at Google Scholar · View at Scopus
  144. B. A. Mysona, A. Y. Shanab, S. L. Elshaer, and A. B. El-Remessy, “Nerve growth factor in diabetic retinopathy: beyond neurons,” Expert Review of Ophthalmology, vol. 9, no. 2, pp. 99–107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  145. M. S. Ola, M. I. Nawaz, A. A. El-Asrar, M. Abouammoh, and A. S. Alhomida, “Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats,” Cellular and Molecular Neurobiology, vol. 33, no. 3, pp. 359–367, 2013. View at Publisher · View at Google Scholar · View at Scopus
  146. G. I. Liou, Y. Fei, N. S. Peachey et al., “Early onset photoreceptor abnormalities induced by targeted disruption of the interphotoreceptor retinoid-binding protein gene,” Journal of Neuroscience, vol. 18, no. 12, pp. 4511–4520, 1998. View at Google Scholar · View at Scopus
  147. M. García-Ramírez, F. Canals, C. Hernández et al., “Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy,” Diabetologia, vol. 50, no. 6, pp. 1294–1303, 2007. View at Publisher · View at Google Scholar · View at Scopus
  148. M. Garcia-Ramírez, C. Hernández, M. Villarroel et al., “Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy,” Diabetologia, vol. 52, no. 12, pp. 2633–2641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  149. G. Casini, E. Catalani, M. Dal Monte, and P. Bagnoli, “Functional aspects of the somatostatinergic system in the retina and the potential therapeutic role of somatostatin in retinal disease,” Histology and Histopathology, vol. 20, no. 2, pp. 615–632, 2005. View at Google Scholar · View at Scopus
  150. E. Carrasco, C. Hernández, A. Miralles, P. Huguet, J. Farrés, and R. Simó, “Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration,” Diabetes Care, vol. 30, no. 11, pp. 2902–2908, 2007. View at Publisher · View at Google Scholar · View at Scopus
  151. C. Hernández, E. Carrasco, R. Casamitjana, R. Deulofeu, J. García-Arumí, and R. Simó, “Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects,” Diabetes Care, vol. 28, no. 8, pp. 1941–1947, 2005. View at Publisher · View at Google Scholar · View at Scopus
  152. R. Simó, A. Lecube, L. Sararols et al., “Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy,” Diabetes Care, vol. 25, no. 12, pp. 2282–2286, 2002. View at Publisher · View at Google Scholar · View at Scopus
  153. R. Simó, E. Carrasco, A. Fonollosa, J. García-Arumí, R. Casamitjana, and C. Hernández, “Deficit of somatostatin in the vitreous fluid of patients with diabetic macular edema,” Diabetes Care, vol. 30, no. 3, pp. 725–727, 2007. View at Publisher · View at Google Scholar · View at Scopus
  154. E. Catalani, D. Cervia, D. Martini et al., “Changes in neuronal response to ischemia in retinas with genetic alterations of somatostatin receptor expression,” European Journal of Neuroscience, vol. 25, no. 5, pp. 1447–1459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  155. D. Cervia, D. Martini, C. Ristori et al., “Modulation of the neuronal response to ischaemia by somatostatin analogues in wild-type and knock-out mouse retinas,” Journal of Neurochemistry, vol. 106, no. 5, pp. 2224–2235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  156. A. D'Alessandro, D. Cervia, E. Catalani, F. Gevi, L. Zolla, and G. Casini, “Protective effects of the neuropeptides PACAP, substance P and the somatostatin analogue octreotide in retinal ischemia: a metabolomic analysis,” Molecular BioSystems, vol. 10, no. 6, pp. 1290–1304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  157. C. Hernández, M. García-Ramírez, L. Corraliza et al., “Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes,” Diabetes, vol. 62, no. 7, pp. 2569–2578, 2013. View at Publisher · View at Google Scholar · View at Scopus
  158. C. Iadecola and J. Anrather, “Stroke research at a crossroad: asking the brain for directions,” Nature Neuroscience, vol. 14, no. 11, pp. 1363–1368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  159. D. Cervia, E. Catalani, M. Dal Monte, and G. Casini, “Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatin,” Journal of Neurochemistry, vol. 120, no. 5, pp. 818–829, 2012. View at Publisher · View at Google Scholar · View at Scopus
  160. A. R. Cervantes-Villagrana, J. Garcia-Román, C. Gonzlez-Espinosa, and M. Lamas, “Pharmacological inhibition of n-methyl d-aspartate receptor promotes secretion of vascular endothelial growth factor in müller cells: effects of hyperglycemia and hypoxia,” Current Eye Research, vol. 35, no. 8, pp. 733–741, 2010. View at Publisher · View at Google Scholar · View at Scopus
  161. J. Kusari, S. X. Zhou, E. Padillo, K. G. Clarke, and D. W. Gil, “Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine,” Investigative Ophthalmology and Visual Science, vol. 51, no. 2, pp. 1044–1051, 2010. View at Publisher · View at Google Scholar · View at Scopus
  162. A. Ebneter, G. Chidlow, J. P. M. Wood, and R. J. Casson, “Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma,” Archives of Ophthalmology, vol. 129, no. 10, pp. 1337–1344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  163. M. Saint-Geniez, A. S. R. Maharaj, T. E. Walshe et al., “Endogenous VEGF is required for visual function: evidence for a survival role on Müller cells and photoreceptors,” PLoS ONE, vol. 3, no. 11, Article ID e3554, 2008. View at Publisher · View at Google Scholar · View at Scopus
  164. R. H. Foxton, A. Finkelstein, S. Vijay et al., “VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma,” The American Journal of Pathology, vol. 182, no. 4, pp. 1379–1390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  165. M. R. Romano, F. Biagioni, G. Besozzi et al., “Effects of bevacizumab on neuronal viability of retinal ganglion cells in rats,” Brain Research, vol. 1478, pp. 55–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  166. M. Azzouz, G. S. Ralph, E. Storkebaum et al., “VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model,” Nature, vol. 429, no. 6990, pp. 413–417, 2004. View at Publisher · View at Google Scholar · View at Scopus
  167. G. Casini, M. Dal Monte, I. Fornaciari, L. Filippi, and P. Bagnoli, “The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases,” Progress in Retinal and Eye Research, vol. 42, pp. 103–129, 2014. View at Publisher · View at Google Scholar · View at Scopus
  168. M. A. Abdelsaid, B. A. Pillai, S. Matragoon, R. Prakash, M. Al-Shabrawey, and A. B. El-Remessy, “Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy,” Journal of Pharmacology and Experimental Therapeutics, vol. 332, no. 1, pp. 125–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  169. A. B. El-Remessy, M. Bartoli, D. H. Platt, D. Fulton, and R. B. Caldwell, “Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration,” Journal of Cell Science, vol. 118, no. 1, pp. 243–252, 2005. View at Publisher · View at Google Scholar · View at Scopus
  170. N. Beazley-Long, J. Hua, T. Jehle et al., “VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor a in vivo and in vitro,” The American Journal of Pathology, vol. 183, no. 3, pp. 918–929, 2013. View at Publisher · View at Google Scholar · View at Scopus
  171. R. M. Perrin, O. Konopatskaya, Y. Qiu, S. Harper, D. O. Bates, and A. J. Churchill, “Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor,” Diabetologia, vol. 48, no. 11, pp. 2422–2427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  172. J. S. Ng, M. A. Bearse Jr., M. E. Schneck, S. Barez, and A. J. Adams, “Local diabetic retinopathy prediction by multifocal ERG delays over 3 years,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1622–1628, 2008. View at Publisher · View at Google Scholar · View at Scopus
  173. Y. Han, M. E. Schneck, M. A. Bearse Jr. et al., “Formulation and evaluation of a predictive model to identify the sites of future diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 45, no. 11, pp. 4106–4112, 2004. View at Publisher · View at Google Scholar · View at Scopus
  174. W. W. Harrison, M. A. Bearse Jr., J. S. Ng et al., “Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes,” Investigative Ophthalmology and Visual Science, vol. 52, no. 2, pp. 772–777, 2011. View at Publisher · View at Google Scholar · View at Scopus
  175. S. Vujosevic, S. Bini, G. Midena, M. Berton, E. Pilotto, and E. Midena, “Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT,” Journal of Diabetes Research, vol. 2013, Article ID 491835, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  176. M. G. Field, D. Yang, Z.-M. Bian, H. R. Petty, and V. M. Elner, “Retinal flavoprotein fluorescence correlates with mitochondrial stress, apoptosis, and chemokine expression,” Experimental Eye Research, vol. 93, no. 4, pp. 548–555, 2011. View at Publisher · View at Google Scholar · View at Scopus
  177. M. G. Field, V. M. Elner, D. G. Puro et al., “Rapid, noninvasive detection of diabetes-induced retinal metabolic stress,” Archives of Ophthalmology, vol. 126, no. 7, pp. 934–938, 2008. View at Publisher · View at Google Scholar · View at Scopus
  178. L. P. Aiello, “Targeting intraocular neovascularization and edema—one drop at a time,” The New England Journal of Medicine, vol. 359, no. 9, pp. 967–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  179. M. Dal Monte, G. Casini, G. la Marca, B. Isacchi, L. Filippi, and P. Bagnoli, “Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice,” Experimental Eye Research, vol. 111, pp. 27–35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  180. A. Lambiase, F. Mantelli, and S. Bonini, “Nerve growth factor eye drops to treat glaucoma,” Drug News and Perspectives, vol. 23, no. 6, pp. 361–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  181. M. Saylor, L. K. McLoon, A. R. Harrison, and M. S. Lee, “Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review,” Archives of Ophthalmology, vol. 127, no. 4, pp. 402–406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  182. N. Cheung, P. Mitchell, and T. Y. Wong, “Diabetic retinopathy,” The Lancet, vol. 376, no. 9735, pp. 124–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  183. A. Robin and D. S. Grover, “Compliance and adherence in glaucoma management,” Indian Journal of Ophthalmology, vol. 59, supplement 1, pp. S93–S96, 2011. View at Publisher · View at Google Scholar
  184. P. E. Fort, M. K. Losiewicz, C. E. N. Reiter et al., “Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistance,” PLoS ONE, vol. 6, no. 10, Article ID e26498, 2011. View at Publisher · View at Google Scholar · View at Scopus
  185. G. P. Misra, R. S. J. Singh, T. S. Aleman, S. G. Jacobson, T. W. Gardner, and T. L. Lowe, “Subconjunctivally implantable hydrogels with degradable and thermoresponsive properties for sustained release of insulin to the retina,” Biomaterials, vol. 30, no. 33, pp. 6541–6547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  186. F. Polato and S. P. Becerra, “Pigment epithelium-derived factor, a protective factor for photoreceptors in Vivo,” Advances in Experimental Medicine and Biology, vol. 854, pp. 699–706, 2016. View at Publisher · View at Google Scholar · View at Scopus
  187. Y. Yoshida, S.-I. Yamagishi, T. Matsui et al., “Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy,” Diabetes/Metabolism Research and Reviews, vol. 25, no. 7, pp. 678–686, 2009. View at Publisher · View at Google Scholar · View at Scopus
  188. J. Tombran-Tink, “PEDF in angiogenic eye diseases,” Current Molecular Medicine, vol. 10, no. 3, pp. 267–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  189. H. Liu, J.-G. Ren, W. L. Cooper, C. E. Hawkins, M. R. Cowan, and P. Y. Tong, “Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 17, pp. 6605–6610, 2004. View at Publisher · View at Google Scholar · View at Scopus
  190. M. Elahy, S. Baindur-Hudson, V. F. Cruzat, P. Newsholme, and C. R. Dass, “Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy,” Journal of Endocrinology, vol. 222, no. 3, pp. R129–R139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  191. Y. Wang, Q. Lu, S. Gao et al., “Pigment epithelium-derived factor regulates glutamine synthetase and l-glutamate/l-aspartate transporter in retinas with oxygen-induced retinopathy,” Current Eye Research, vol. 40, no. 12, pp. 1232–1244, 2015. View at Publisher · View at Google Scholar · View at Scopus
  192. R. Longeras, K. Farjo, M. Ihnat, and J.-X. Ma, “A PEDF-derived peptide inhibits retinal neovascularization and blocks mobilization of bone marrow-derived endothelial progenitor cells,” Experimental Diabetes Research, vol. 2012, Article ID 518426, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  193. Y. Liu, L. F. Leo, C. McGregor, A. Grivitishvili, C. J. Barnstable, and J. Tombran-Tink, “Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2Akita mice,” Molecular Medicine, vol. 18, pp. 1387–1401, 2012. View at Publisher · View at Google Scholar
  194. V. Vigneswara, M. Esmaeili, L. Deer, M. Berry, A. Logan, and Z. Ahmed, “Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration,” Molecular and Cellular Neuroscience, vol. 68, pp. 212–221, 2015. View at Publisher · View at Google Scholar · View at Scopus
  195. D. Cervia and G. Casini, “The neuropeptide systems and their potential role in the treatment of mammalian retinal ischemia: a developing story,” Current Neuropharmacology, vol. 11, no. 1, pp. 95–101, 2013. View at Google Scholar · View at Scopus
  196. M. Dal Monte, C. Petrucci, A. Cozzi, J. P. Allen, and P. Bagnoli, “Somatostatin inhibits potassium-evoked glutamate release by activation of the sst2 somatostatin receptor in the mouse retina,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 367, no. 2, pp. 188–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  197. T. Atlasz, K. Szabadfi, P. Kiss et al., “Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects,” Annals of the New York Academy of Sciences, vol. 1200, pp. 128–139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  198. T. Seki, H. Itoh, T. Nakamachi et al., “Suppression of rat retinal ganglion cell death by PACAP following transient ischemia induced by high intraocular pressure,” Journal of Molecular Neuroscience, vol. 43, no. 1, pp. 30–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  199. C. Hlscher, “Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection,” CNS Drugs, vol. 26, no. 10, pp. 871–882, 2012. View at Publisher · View at Google Scholar · View at Scopus
  200. Y. Zhang, J. Zhang, Q. Wang et al., “Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats,” Investigative Ophthalmology and Visual Science, vol. 52, no. 1, pp. 278–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  201. Y. Fan, K. Liu, Q. Wang, Y. Ruan, Y. Zhang, and W. Ye, “Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis,” Molecular Vision, vol. 20, pp. 1557–1568, 2014. View at Google Scholar · View at Scopus
  202. C. Hernandez, P. Bogdanov, L. Corraliza et al., “Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes,” Diabetes, vol. 65, no. 1, pp. 172–187, 2016. View at Google Scholar
  203. Y. Gong, Z.-P. Chang, R.-T. Ren et al., “Protective effects of adeno-associated virus mediated brain-derived neurotrophic factor expression on retinal ganglion cells in diabetic rats,” Cellular and Molecular Neurobiology, vol. 32, no. 3, pp. 467–475, 2012. View at Publisher · View at Google Scholar · View at Scopus
  204. B.-A. Berk, S. Vogler, T. Pannicke et al., “Brain-derived neurotrophic factor inhibits osmotic swelling of rat retinal glial (Müller) and bipolar cells by activation of basic fibroblast growth factor signaling,” Neuroscience, vol. 295, pp. 175–186, 2015. View at Publisher · View at Google Scholar · View at Scopus
  205. H. P. Hammes, H. J. Federoff, and M. Brownlee, “Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes,” Molecular Medicine, vol. 1, no. 5, pp. 527–534, 1995. View at Google Scholar · View at Scopus
  206. V. Colafrancesco, M. Coassin, S. Rossi, and L. Aloe, “Effect of eye NGF administration on two animal models of retinal ganglion cells degeneration,” Annali dell'Istituto Superiore di Sanita, vol. 47, no. 3, pp. 284–289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  207. S. Majumdar and R. Srirangam, “Potential of the bioflavonoids in the prevention/treatment of ocular disorders,” Journal of Pharmacy and Pharmacology, vol. 62, no. 8, pp. 951–965, 2010. View at Publisher · View at Google Scholar · View at Scopus
  208. B. Kumar, S. K. Gupta, T. C. Nag et al., “Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats,” Experimental Eye Research, vol. 125, pp. 193–202, 2014. View at Publisher · View at Google Scholar · View at Scopus
  209. F. Ghadiri Soufi, E. Arbabi-Aval, M. Rezaei Kanavi, and H. Ahmadieh, “Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats,” Clinical and Experimental Pharmacology and Physiology, vol. 42, no. 1, pp. 63–68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  210. F. G. Soufi, M. Vardyani, R. Sheervalilou, M. Mohammadi, and M. H. Somi, “Long-term treatment with resveratrol attenuates oxidative stress pro-inflammatory mediators and apoptosis in streptozotocin-nicotinamide-induced diabetic rats,” General Physiology and Biophysics, vol. 31, no. 4, pp. 431–438, 2012. View at Publisher · View at Google Scholar · View at Scopus
  211. A. S. Yar, S. Menevse, I. Dogan et al., “Investigation of ocular neovascularization-related genes and oxidative stress in diabetic rat eye tissues after resveratrol treatment,” Journal of Medicinal Food, vol. 15, no. 4, pp. 391–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  212. T. Mrudula, P. Suryanarayana, P. N. B. S. Srinivas, and G. B. Reddy, “Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina,” Biochemical and Biophysical Research Communications, vol. 361, no. 2, pp. 528–532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  213. Z.-F. Zuo, Q. Zhang, and X.-Z. Liu, “Protective effects of curcumin on retinal Müller cell in early diabetic rats,” International Journal of Ophthalmology, vol. 6, no. 4, pp. 422–424, 2013. View at Publisher · View at Google Scholar · View at Scopus
  214. S. K. Gupta, B. Kumar, T. C. Nag et al., “Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms,” Journal of Ocular Pharmacology and Therapeutics, vol. 27, no. 2, pp. 123–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  215. B. Kumar, S. K. Gupta, B. P. Srinivasan et al., “Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats,” Microvascular Research, vol. 87, pp. 65–74, 2013. View at Publisher · View at Google Scholar · View at Scopus
  216. A. S. Ibrahim, M. M. El-Shishtawy, A. Peña Jr., and G. I. Liou, “Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation,” Molecular Vision, vol. 16, pp. 2033–2042, 2010. View at Google Scholar · View at Scopus
  217. S. A. Elgayar, S. A. Eltony, A. A. Sayed, and M. M. Abdel-Rouf, “Genistein treatment confers protection against gliopathy and vasculopathy of the diabetic retina in rats,” Ultrastructural Pathology, vol. 39, no. 6, pp. 385–394, 2015. View at Publisher · View at Google Scholar
  218. M. Nebbioso, M. Federici, D. Rusciano, M. Evangelista, and N. Pescosolido, “Oxidative stress in preretinopathic diabetes subjects and antioxidants,” Diabetes Technology and Therapeutics, vol. 14, no. 3, pp. 257–263, 2012. View at Publisher · View at Google Scholar · View at Scopus
  219. K. C. Silva, M. A. B. Rosales, D. E. Hamassaki et al., “Green tea is neuroprotective in diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 54, no. 2, pp. 1325–1336, 2013. View at Publisher · View at Google Scholar · View at Scopus
  220. R. A. Kowluru, B. Menon, and D. L. Gierhart, “Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1645–1651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  221. R. A. Kowluru, Q. Zhong, J. M. Santos, M. Thandampallayam, D. Putt, and D. L. Gierhart, “Beneficial effects of the nutritional supplements on the development of diabetic retinopathy,” Nutrition and Metabolism, vol. 11, no. 1, article 8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  222. Age-Related Eye Disease Study 2 Research Group, “Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial,” Journal of the American Medical Association, vol. 309, no. 19, pp. 2005–2015, 2013. View at Google Scholar
  223. R. Simó and C. Hernández, “Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives,” Trends in Endocrinology and Metabolism, vol. 25, no. 1, pp. 23–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  224. C. E. Riva, E. Logean, and B. Falsini, “Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina,” Progress in Retinal and Eye Research, vol. 24, no. 2, pp. 183–215, 2005. View at Publisher · View at Google Scholar · View at Scopus
  225. F. Formaz, C. E. Riva, and M. Geiser, “Diffuse luminance flicker increases retinal vessel diameter in humans,” Current Eye Research, vol. 16, no. 12, pp. 1252–1257, 1997. View at Publisher · View at Google Scholar · View at Scopus
  226. A. Lecleire-Collet, I. Audo, M. Aout et al., “Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy,” Investigative Ophthalmology and Visual Science, vol. 52, no. 6, pp. 2861–2867, 2011. View at Publisher · View at Google Scholar · View at Scopus
  227. T. T. Nguyen, R. Kawasaki, J. J. Wang et al., “Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy,” Diabetes Care, vol. 32, no. 11, pp. 2075–2080, 2009. View at Publisher · View at Google Scholar · View at Scopus
  228. M. Tyrberg, U. Lindblad, A. Melander, M. Lövestam-Adrian, V. Ponjavic, and S. Andréasson, “Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy,” Documenta Ophthalmologica, vol. 123, no. 3, pp. 193–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  229. A. Mishra and E. A. Newman, “Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy,” Glia, vol. 58, no. 16, pp. 1996–2004, 2010. View at Publisher · View at Google Scholar · View at Scopus
  230. S. S. F. Cheung, J. W. C. Leung, A. K. M. Lam et al., “Selective over-expression of endothelin-1 in endothelial cells exacerbates inner retinal edema and neuronal death in ischemic retina,” PLoS ONE, vol. 6, no. 10, Article ID e26184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  231. M. Tonari, T. Kurimoto, T. Horie, T. Sugiyama, T. Ikeda, and H. Oku, “Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation,” Investigative Ophthalmology and Visual Science, vol. 53, no. 7, pp. 3490–3500, 2012. View at Publisher · View at Google Scholar · View at Scopus
  232. A. Z. Minton, N. R. Phatak, D. L. Stankowska et al., “Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma,” PLoS ONE, vol. 7, no. 8, Article ID e43199, 2012. View at Publisher · View at Google Scholar · View at Scopus
  233. X.-S. Mi, X. Zhang, Q. Feng, A. C. Y. Lo, S. K. Chung, and K.-F. So, “Progressive retinal degeneration in transgenic mice with overexpression of endothelin-1 in vascular endothelial cells,” Investigative Ophthalmology and Visual Science, vol. 53, no. 8, pp. 4842–4851, 2012. View at Publisher · View at Google Scholar · View at Scopus
  234. J. C. Chou, S. D. Rollins, M. Ye, D. Batlle, and A. A. Fawzi, “Endothelin receptor-a antagonist attenuates retinal vascular and neuroretinal pathology in diabetic mice,” Investigative Ophthalmology and Visual Science, vol. 55, no. 4, pp. 2516–2525, 2014. View at Publisher · View at Google Scholar · View at Scopus
  235. J. Kusari, S. Zhou, E. Padillo, K. G. Clarke, and D. W. Gil, “Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats,” Investigative Ophthalmology and Visual Science, vol. 48, no. 11, pp. 5152–5159, 2007. View at Publisher · View at Google Scholar · View at Scopus
  236. D. F. Sena and K. Lindsley, “Neuroprotection for treatment of glaucoma in adults,” Cochrane Database Of Systematic Reviews, vol. 2, Article ID CD006539, 2013. View at Google Scholar · View at Scopus
  237. S. A. Jayakody, A. Gonzalez-Cordero, R. R. Ali, and R. A. Pearson, “Cellular strategies for retinal repair by photoreceptor replacement,” Progress in Retinal and Eye Research, vol. 46, pp. 31–66, 2015. View at Publisher · View at Google Scholar · View at Scopus
  238. D. Ruminski, B. L. Sikorski, D. Bukowska et al., “OCT angiography by absolute intensity difference applied to normal and diseased human retinas,” Biomedical Optics Express, vol. 6, no. 8, pp. 2738–2754, 2015. View at Publisher · View at Google Scholar · View at Scopus
  239. T. Bek, “Fine structure in diabetic retinopathy lesions as observed by adaptive optics imaging. A qualitative study,” Acta Ophthalmologica, vol. 92, no. 8, pp. 753–758, 2014. View at Publisher · View at Google Scholar · View at Scopus
  240. S. Arichika, A. Uji, T. Murakami et al., “Retinal hemorheologic characterization of early-stage diabetic retinopathy using adaptive optics scanning laser ophthalmoscopy,” Investigative Ophthalmology and Visual Science, vol. 55, no. 12, pp. 8513–8522, 2014. View at Publisher · View at Google Scholar · View at Scopus
  241. R. Gaudana, J. Jwala, S. H. S. Boddu, and A. K. Mitra, “Recent perspectives in ocular drug delivery,” Pharmaceutical Research, vol. 26, no. 5, pp. 1197–1216, 2009. View at Publisher · View at Google Scholar · View at Scopus